Folic Acid Functionalized Chlorin e6-Superparamagnetic Iron Oxide Nanocarriers as a Theranostic Agent for MRI-Guided Photodynamic Therapy

J Biomed Nanotechnol. 2021 Feb 28;17(2):205-215. doi: 10.1166/jbn.2021.3021.

Abstract

Imaging-guided cancer theranostic is a promising strategy for cancer diagnostic and therapeutic. Photodynamic therapy (PDT), as an approved treatment modality, is limited by the poor solubility and dispersion of photosensitizers (PS) in biological fluids. Herein, it is demonstrated that superparamagnetic iron oxide (SPIO)-based nanoparticles (SCFs), prepared by conjugated with Chlorin e6 (Ce6) and modified with folic acid (FA) on the surface, can be used as versatile drug delivery vehicles for effective PDT. The nanoparticles are great carriers for photosensitizer Ce6 with an extremely high loading efficiency. In vitro fluorescence imaging and in vivo magnetic resonance imaging (MRI) results indicated that SCFs selectively accumulated in tumor cells. Under near-infrared laser irradiation, SCFs were confirmed to be capable of inducing low cell viability of RM-1 cells In vitro and displaying efficient tumor ablation with negligible side effects in tumor-bearing mice models.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Chlorophyllides
  • Ferric Compounds
  • Folic Acid
  • Magnetic Iron Oxide Nanoparticles
  • Magnetic Resonance Imaging
  • Mice
  • Mice, Inbred BALB C
  • Nanoparticles*
  • Photochemotherapy*
  • Photosensitizing Agents / pharmacology
  • Porphyrins*
  • Precision Medicine
  • Theranostic Nanomedicine

Substances

  • Chlorophyllides
  • Ferric Compounds
  • Photosensitizing Agents
  • Porphyrins
  • ferric oxide
  • phytochlorin
  • Folic Acid